AKT1 and neoplasm: In the process of tumor inhibition, apigenin modulates a couple of protein kinases and signaling pathways, including MAPK/ERK, PI3K/Akt, JAK/STAT, NF‐κB, and Wnt/β‐catenin (Yan et al., 2017).